Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.03 – $0.20
53% from low
Exchange
OTC Link
CS
Borrow rate
31.56%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $224.0K | $299.0K | $116.0K | $5.0K | $0 | $0 | $0 | $0 |
| Cost of revenue | $150.0K | $141.0K | $67.0K | $13.0K | $12.0K | $12.0K | $11.0K | $1.0K |
| Gross profit | $74.0K | $158.0K | $49.0K | −$8.0K | −$12.0K | −$12.0K | −$11.0K | −$1.0K |
| Gross margin | 33.0% | 52.8% | 42.2% | -160.0% | — | — | — | — |
| R&D | $7.9M | $6.7M | $7.4M | $8.1M | $6.6M | $3.8M | $4.0M | $3.3M |
| Operating income | −$13.2M | −$10.6M | −$13.3M | −$11.7M | −$12.5M | −$6.7M | −$8.3M | −$4.3M |
| EBITDA | −$13.2M | −$10.6M | −$13.1M | −$11.7M | −$12.5M | −$6.5M | −$8.8M | −$4.3M |
| Net income | −$13.4M | −$10.6M | −$13.2M | −$11.7M | −$12.5M | −$6.6M | −$8.8M | −$4.5M |
| Net margin | -5995.1% | -3543.1% | -11346.6% | -234760.0% | — | — | — | — |
| EPS (diluted) | -0.26 | -0.18 | -0.19 | -0.16 | -0.15 | -0.07 | -0.10 | -0.05 |
Annual figures · source: Financial Modeling Prep
NYMOX PHARM CORP
No one on the platform currently holds NYMXF.
No tracked institution reports a position in NYMXF as of their last filing.
No one on the platform has traded NYMXF yet.
| $14M |
| — |
| IMUCEOM Pharmaceuticals Holdings, Inc. | $0.27 | +22.73% | $34M | — |
| INTIInhibitor Therapeutics, Inc. | $0.08 | -11.11% | $14M | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$NYMXF We are all set now and I know who the first 2 patients will be! The Skipper and Gilligan are old and probably need a shot in the ass. Hopefully they are near the Island of Roatan and have the ability to float over there. Roatan is a Metropolis being 33 miles long and a population of 100,000 people with apparently very low medical standards. I’m sure everyone wants to get there medical care there and have already bought their tickets……is there an airport there?
View on StockTwits ↗$NYMXF 12 years 😆 ,robo been saying Come on usa..4 more years a you will be our true hero!! ra ra ra
View on StockTwits ↗$NYMXF I’m hearing Dr A has a new plan for your ass which is far better than the first 2. The first one was sticking a needle up your ass, and the second one was taking advantage of your ass for money. There are other terms for the second one! The new venture is in the weight loss business and its ok for both medical and personal reasons. The process can be done as an outpatient procedure or simply in the privacy of your home. Just before you eat you stick the Dr A Diet Vacuum up your ass and turn it in high. After 10 seconds of high suction, you start eating and the Dr A Diet Vacuum will suck the food out faster than you eat it. Dr A knows and relies on many different types of asses, and he Guarantees you feel the difference of his method of weight loss. A side benefit that has not been fully established is that it cures all kinds of flu and cancer. He requests that everyone send in as much money as possible, cash is preferred, to the Nymox Headquarters.
View on StockTwits ↗$NYMXF so all submissions refused and resubmissions required with additional funding they don’t have. So dead for years again… Great.
View on StockTwits ↗$NYMXF aquaman - wow. Thank you very much. looks like things are turning around.
View on StockTwits ↗$NYMXF The recent stock price activity was actually a case of Major Constipation probably started by that basement living 12-year-old Texas Broker who calls people regarding 10 cent stocks. Now, You are seeing real stock price Movement that truly Stinks. It’s a Colossal Size Colonoscopy Quality Huge Movement of Nymox Stock Price to record levels.
View on StockTwits ↗$NYMXF https://www.sec.gov/Archives/edgar/data/1018735/000164033426000983/nymox_6k.htm
View on StockTwits ↗$NYMXF Now that our Leader has finally, although about 2 years late, admitted the UK Rejected the Application I’m so glad we listen to Dr A and Rejected the Ascella opportunity. Ascella would have invested Millions of Dollars, redone the Trials to FDA Standards and Requirements, had 2 Board Seats which would have negatively impacted our leader Dr A, had various world wide Jurisdictions demanding drug applications for approval and Nymox would probably be $50.00 priced stock now. We are so much better off now with 8 Rejections. Dr A has such a great idea and I’m so excited we are starting a new round of submitting poor quality applications starting with the FDA. You Dr A lovers are amazing.
View on StockTwits ↗$NYMXF Diddy, My hat is off to you. You spotted this Fraud and warned everyone a long time ago. Thank you
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.